These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recalcitrant rhinosinusitis, innate immunity, and mannose-binding lectin. Justice JM; Sleasman JW; Lanza DC Ann Otol Rhinol Laryngol; 2015 Feb; 124(2):102-6. PubMed ID: 25063683 [TBL] [Abstract][Full Text] [Related]
4. Mannose-binding lectin deficiency and predisposition to recurrent infection in adults. Holdaway J; Deacock S; Williams P; Karim Y J Clin Pathol; 2016 Aug; 69(8):731-6. PubMed ID: 26837313 [TBL] [Abstract][Full Text] [Related]
5. Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis. Kawashima H; Kagami SI; Kashiwakuma D; Takahashi K; Yokota M; Furuta S; Iwamoto I Rheumatol Int; 2017 Mar; 37(3):369-376. PubMed ID: 27999943 [TBL] [Abstract][Full Text] [Related]
6. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604 [TBL] [Abstract][Full Text] [Related]
7. Mannose-binding lectin (MBL) deficiency and tuberculosis infection in patients with ankylosing spondylitis. Nisihara R; Skare T; Maestri V; Alegretti JS; Campos APB; Messias-Reason I Clin Rheumatol; 2018 Feb; 37(2):555-558. PubMed ID: 28879439 [TBL] [Abstract][Full Text] [Related]
8. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs. Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948 [TBL] [Abstract][Full Text] [Related]
10. Undetectable mannose binding lectin is associated with HRCT proven bronchiectasis in rheumatoid arthritis (RA). Makin K; Easter T; Kemp M; Kendall P; Bulsara M; Coleman S; Carroll GJ PLoS One; 2019; 14(4):e0215051. PubMed ID: 30970022 [TBL] [Abstract][Full Text] [Related]
11. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Troelsen LN; Garred P; Madsen HO; Jacobsen S Arthritis Rheum; 2007 Jan; 56(1):21-9. PubMed ID: 17195187 [TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory associations of mannose-binding lectin in 219 adults with IgG subclass deficiency. Barton JC; Barton JC; Bertoli LF BMC Immunol; 2019 May; 20(1):15. PubMed ID: 31117958 [TBL] [Abstract][Full Text] [Related]
13. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin? Troelsen LN; Garred P; Jacobsen S J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521 [TBL] [Abstract][Full Text] [Related]
14. Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis. Troelsen LN; Garred P; Christiansen B; Torp-Pedersen C; Christensen IJ; Narvestad E; Jacobsen S Mol Immunol; 2010 Jan; 47(4):713-8. PubMed ID: 19939454 [TBL] [Abstract][Full Text] [Related]
15. Mannose-binding Lectin Deficiency in Patients with a History of Recurrent Infections. Rashidi E; Fazlollahi MR; Zahedifard S; Talebzadeh A; Kazemnejad A; Saghafi S; Pourpak Z Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):69-74. PubMed ID: 26996114 [TBL] [Abstract][Full Text] [Related]
16. Low maternal serum concentrations of mannose-binding lectin are associated with the risk of shorter duration of pregnancy and lower birthweight. Koucký M; Malíčková K; Kopřivová H; Cindrová-Davies T; Hrbáčková H; Černý A; Šimják P; Pařízek A; Zima T Scand J Immunol; 2018 Jul; 88(1):e12675. PubMed ID: 29758096 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Mannose-Binding Lectin is a Useful Approach to Predict the Risk of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation. Radnay ZB; Udvardy M; Papp M; Hársfalvi J; Rejto L; Pál I; Illés Á; Kiss A Transplant Proc; 2016 Dec; 48(10):3397-3405. PubMed ID: 27931588 [TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420 [TBL] [Abstract][Full Text] [Related]
19. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency. Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622 [TBL] [Abstract][Full Text] [Related]
20. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]